The Organ Preservation Market plays a critical role in the field of transplantation by providing solutions for the safe storage and transport of organs before transplantation procedures. This market involves the development and implementation of innovative technologies and solutions to extend the viability of organs and enhance transplant outcomes. Key components include organ preservation solutions, devices, and techniques that maintain organs at optimal conditions, preserving their functionality and reducing the risk of ischemic damage.
Major drivers of the Organ Preservation Market include the increasing demand for organ transplants, advancements in preservation technologies, and a growing emphasis on improving post-transplantation results. Innovative methods such as hypothermic and normothermic preservation, machine perfusion, and cryopreservation contribute to the market's growth by addressing specific organ preservation challenges.
Challenges involve the limited availability of donor organs, the complexity of matching donors with recipients, and the need for continuous advancements to improve preservation techniques. The market is globally distributed, with North America and Europe being prominent regions due to well-established healthcare infrastructures and robust organ transplant programs. As the Organ Preservation Market continues to evolve, it remains a vital component of the broader effort to enhance the success rates and accessibility of organ transplantation globally.
Market Research Future’s (MRFR’s) detailed report ensures growth in the organ preservation market share by 5.8% CAGR during the forecast period (2023-2030). It would leap from its previous valuation of USD 0.31 billion in 2022 to exceed the estimated value by the end of 2023. Organ preservation is now an important part of the healthcare sector as it can help a patient regain his or her vitality through transplantation procedure.
The global organ preservation market is getting driven by the rising number of people donating their organs for research purposes or applications in transplantations. Innovations in surgeries have reduced the risk of the organ failure owing to which the demand for organs is growing. This is getting further boosted by government initiatives and steps taken by NGOs who are encouraging people in donating their organs. Quite a few players have already entered the market and are developing various strategies to take the market. At the same time, new entrants are showing keen interests in investment.
However, the organ preservation market often gets daunted by the high price of organs and difficult transplantation procedures. On the other hand, development in cell therapy could prevent the market from achieving the predicted growth in coming years.
Competitive Landscape:
Influential companies in the organ preservation market players are BioLife Solutions, Inc., Xvivo Perfusion AB, Bristol-Myers Squibb, Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Lifeline Scientific, Claris Lifesciences Limited, 21st Century Medicine, ToleroTech, Inc., and CryoLife, Inc. MRFR, while enlisting these companies, in the report also tracked in detail their recent operations regarding product launch, merger, acquisition, and other methods.
Segmentation:
MRFR in their report on the global organ preservation market segments the market by the technique of preservation, and preservation solution, organ type, end-user.
By preservation solution, the organ preservation market comprises custodiol HTK, University of Wisconsin (UW) solution, citrate solutions, celsior solution, perfadex, and collins solution.
Based on the organ type, the organ preservation market consists kidney, liver, lungs, heart, and others. Lifestyle changes have triggered a rise in the kidney segment.
Upon considering the technique of preservation, the organ preservation market includes static cold storage, and dynamic cold storage. The dynamic cold storage consists normothermic machine perfusion, hypothermic machine perfusion, and oxygen persufflation.
Based on the end-user, the organ preservation market is segmented into hospitals, organ banks, and clinics, and others.
Regional Analysis:
The region-specific analysis of the organ preservation market insights, as discussed by MRFR, includes the study of regions, namely, North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Market in North America is gaining traction from several sectors such as the growing awareness regarding organ preservation, increasing number of service providers, several financial benefits provided by banks and other institutions for organ preservation set up, superior healthcare structure, and others. These factors have ensured a smooth path ahead for the regional market and founded a proper base for the same. North America is the leading market now, and during the forecast period, it is expected to retain its market dominance.
Europe’s organ preservation market is the second biggest one. The regional market is benefitting much from common features that it shares with the North American region. However, other pointers such as robust support from various organizations and low-cost service are aiding both regions in taking forward their market.
The APAC market is expected to benefit the most from the revamping structures of India and China. Both these nations are investing substantially to change their present healthcare infrastructure. The huge population of the region is also helping the market in its growth. New preservation centers are growing up due to which the market is going to use as leverage. Also, the region’s appeal, on a global scale, as a possible expansion plan for companies is quite alluring.
For more information visit at MarketResearchFuture
Other Trending Reports
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian